Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,358.00    0.00 (0.00%)
Bid:
2,300.00
Ask:
2,698.00
Spread: 398.00 (17.304%)
Market Cap: £28.44b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Scrip Alternative

27 Aug 2019 17:21

RNS Number : 3207K
SSE PLC
27 August 2019
 

SSE PLC

 

FINAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2019

SCRIP ALTERNATIVE

SSE plc was notified on 26 August 2019 that a total of 27,094 shareholders have elected to receive the final dividend for the year ended 31 March 2019 of 68.2 pence per ordinary share in respect of 306,737,887 ordinary shares in the form of Scrip dividend. This will result in a reduction in final dividend cash funding of £209,195,239.

A total of 19,086,291 new ordinary shares, fully paid, will be issued on 20 September 2019, representing an increase of 1.86% on the issued share capital (excluding treasury shares) on the dividend record date of 26 July 2019. The relevant Scrip Reference Share Price was 1,096 pence per ordinary share.

Taking account of subscription to Scrip over both interim and final dividends, take-up of the 2018/19 dividend will be 35%. In May 2018, SSE confirmed its intention to buy back shares where take-up of the full year dividend exceeds 20%, starting in financial year 2018/19. SSE therefore intends to initiate a share buy back, in the period following the final dividend payment for the year ended 31 March 2019, in accordance with the authority granted by shareholders at SSE's Annual General Meeting on 18 July 2019 and Chapter 12 of the Listing Rules. The number of ordinary shares to be purchased will not exceed 13,420,470 ordinary shares, and the maximum pecuniary amount allocated to the Scrip buy-back is £150,000,000. SSE intends to complete this share buy-back by 31 March 2020.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVQDLFLKVFFBBD
Date   Source Headline
9th Jun 20264:34 pmRNSDirector/PDMR Shareholding
9th Jun 20263:47 pmRNSNotification of Admission to Trading
5th Jun 202612:39 pmRNSDirector/PDMR Shareholding
2nd Jun 20263:44 pmRNSIssue of Hybrid Capital Securities
1st Jun 202612:30 pmRNSAdmission to Trading
1st Jun 202612:21 pmRNSTotal Voting Rights
28th May 20267:00 amRNSPreliminary Results
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20268:43 amRNSTotal Voting Rights
29th Apr 20264:38 pmRNSHolding(s) in Company
22nd Apr 20268:42 amRNSHolding(s) in Company
9th Apr 20264:45 pmRNSDirector/PDMR Shareholding
7th Apr 20262:27 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:01 amEQSSSE PLC: Trading Update
1st Apr 20267:01 amEQSTotal Voting Rights
20th Mar 20262:57 pmRNSAdmission of Further Securities to Trading
9th Mar 20263:06 pmRNSDirector/PDMR Shareholding
9th Mar 20263:06 pmRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amEQSTotal Voting Rights
2nd Mar 20267:00 amRNSSSENT accepts Ofgem’s RIIO-T3 Final Determination
24th Feb 20267:00 amRNSNotice of Redemption
12th Feb 20264:05 pmRNSDirector/PDMR Shareholding
11th Feb 20263:15 pmRNSHolding(s) in Company
10th Feb 20264:44 pmRNSDirector/PDMR Shareholding
4th Feb 202611:46 amRNSDirector/PDMR Shareholding
4th Feb 20267:00 amRNSQ3 Trading Statement
2nd Feb 20267:00 amEQSSSE PLC: Total Voting Rights
30th Jan 20262:52 pmRNSDirector/PDMR Shareholding
29th Jan 202612:00 pmRNSDirector/PDMR Shareholding
21st Jan 20264:15 pmRNSAdditional Admission Application
14th Jan 20267:25 amRNSSSE secures 1.4GW CfD for Berwick Bank Wind Farm
8th Jan 20263:28 pmRNSScrip Alternative
8th Jan 20262:54 pmRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
30th Dec 202510:33 amRNSDirector/PDMR Shareholding
30th Dec 202510:33 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSSSEN Transmission-£1bn Facility backed by the NWF
19th Dec 20257:00 amRNSSSEN Transmission-£1bn Facility backed by the NWF
11th Dec 202511:40 amRNSScrip Dividend Scheme
10th Dec 20252:35 pmRNSHolding(s) in Company
10th Dec 20252:06 pmRNS2025 Sustainability Financing Framework
9th Dec 20253:50 pmRNSHolding(s) in Company
9th Dec 20253:48 pmRNSHolding(s) in Company
9th Dec 20251:52 pmRNSHolding(s) in Company
9th Dec 20251:41 pmRNSDirector/PDMR Shareholding
8th Dec 20251:14 pmRNSDirector/PDMR Shareholding
4th Dec 202511:44 amRNSHolding(s) in Company
4th Dec 20257:01 amRNSSSENT response to RIIO-T3 Final Determination
3rd Dec 202510:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.